Grace Halsey

ENDO 2021: Fewer than 1-in-10 older adults with a hip fracture had been prescribed bone-directed treatment in the 6 months prior to the incident, according to research on trends in treatment.

How do clinicians who treat asthma rate their own adherence to tenets of evidence-based guidelines? Lead authors on analyses of a national survey respond.

In percentage of population fully vaccinated against COVID-19, Alaska currently leads and Utah brings up the rear. Find out which states are in between.

Primary care clinicians provide ~60% of asthma care in the US. The challenge is real and we discussed details with experts Drs Michelle Cloutier and Lara Akinbami.

Study: Anosmia, myalgias, and headache were the most common extrapulmonary symptoms seen in COVID-19 patients at first presentation, say investigators.

Suspicion for ACS in women was lower than that for men even in the presence of significant risk factors for heart attack, study authors report.

We compiled the top trending Myths about the COVID-19 vaccine in wide circulation and added the Facts to help you educate your patients.

Using metabolomic profiling from more than 11 000 individuals, researchers identified common pathways linking seemingly unrelated diseases that often co-occur.

Post-hoc analysis of the phase 3 KRONOS study concluded that the benefits in COPD exacerbation seen were not driven by the small subgroup with a prior history of exacerbations.

New and highly specific migraine drugs have significantly changed the clinical landscape for patients. We talked with Peter McAllister, MD, about where the research goes next.

The CDC on March 8, 2021, lifted some COVID-19 restrictions for fully vaccinated Americans, including the need for a mask and social distancing in certain situations.

Transplant-free survival was found lower among patients with pulmonary hypertension-COPD than among those with IPAH in a new study published in CHEST.

Routine adult vaccination rates have yet to reach pre-pandemic levels, according to a report in MMWR this week. Which vaccines are most affected and which groups are lagging?

The COVID-19 vaccine development story of 2020 was the focus when infectious disease specialist and AIDS researcher Dr Rodger MacArthur spoke with Patient Care Online in January.

Statistically significant reductions in annual exacerbation rates were seen across baseline eosinophil and exhaled FeNO level and allergy status with telepezumab, in the phase 3 NAVIGATOR trial.

Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.

AAAAI Virtual Annual Meeting. Severity of underlying airways disease and not prior use of corticosteroids posed a risk of more severe COVID-19, a new study finds.

Dupilumab therapy for 4 weeks in adults with severe atopic dermatitis resulted in significant improvements in clinical outcomes with no adverse events reported.

Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.

Patients with COVID-19 who have asthma share a similar risk of hospitalization with patients with the infection who do not have asthma, according to new research.

COVID-19 vaccination progress based on proportion of vaccines administered is currently best in New Mexico and worst in Tennessee. Find out which states are in between.

AAAAI Virtual Annual Meeting. Among patients with asthma, wearing a mask, regardless of type or duration of use, had no significant effect on oxygen saturation.

AAAAI Virtual Annual Meeting. Two-thirds of severe asthma patients dependent upon oral corticosteroids stopped or maximally reduced use, according to the trial data.

Post-COVID-19 health care delivery will depend, in part, on patient preference and lingering concerns. New research identifies 4 patient groups with divergent feelings.

Cannabis researchers Drs Carrie Cuttler and Rebecca Craft discuss their findings, their labs at WSU, their new research, and what makes this kind of research a challenge.

As states implement the CDC ACIP's COVID-19 vaccination priorities, they are revising them as needed based on federal, state, and local conditions. Here is a recent snapshot.

FDA approved the fixed-dose combination heart failure drug sacubitril/valsartan to reduce risk of CV death and hospitalization in patients with chronic heart failure.

To ensure COVID-19 vaccination priority for the sickest CVD patients, the ACC statement identifies highest risk conditions within CVD to aid clinician decision making.

As a group, Americans who want to wait and see how the COVID-19 vaccine works for others are younger and more diverse than those who want it ASAP.

Authors of 2 large cannabis-user database analyses discuss the possible reasons for observed dose increase over time by individuals using inhaled cannabis for pain relief.